Grifols: Promonitor Quick Immunoassays

Grifols has launched a two-test point-of-care system to monitor levels of infliximab, a medication used to treat a variety of chronic inflammatory conditions. The rapid POC tests, part of Grifols' Promonitor Quick immunoassays, deliver results in 20 minutes using a fingerstick of whole blood. Promonitor Quick leverages lateral flow immunochromatography and eliminates pre-analytical sample processing. It is portable and enables clinicians and laboratory staff to measure levels of infliximab or detect its antibodies. Results appear on a reader while the patient waits, enabling easy optimization of treatment doses, Grifols said.